Showing results (1291-1300 of 1,402) with videos related to

Sort By:
Pageof 141
Vaccine|June 29, 2015
Self-administration of intranasal influenza vaccine: Immunogenicity and volunteer acceptanceTimothy H Burgess, Clinton K Murray, Mary F Bavaro, et al.
Frontiers in Immunology|April 17, 2025
Distinct Omicron longitudinal memory T cell profile and T cell receptor repertoire associated with COVID-19 hospitalisationGavin Markey, Joseph McLaughlin, Darren McDaid, et al.
Plos Neglected Tropical Diseases|December 28, 2007
A comparative study of leptospirosis and dengue in Thai childrenDaniel H Libraty, Khin S A Myint, Clinton K Murray, et al.
Transfusion|February 1, 2013
Transfusion-transmitted human T-lymphotropic virus Type I infection in a United States military emergency whole blood transfusion recipient in Afghanistan, 2010Shilpa Hakre, Mark M Manak, Clinton K Murray, et al.
Bioorganic & Medicinal Chemistry|July 1, 1997
Trioxane dimers have potent antimalarial, antiproliferative and antitumor activities in vitroG H Posner, P Ploypradith, W Hapangama, et al.
Plos One|June 3, 2021
Serological profiles of pan-coronavirus-specific responses in COVID-19 patients using a multiplexed electro-chemiluminescence-based testing platformSidhartha Chaudhury, Jack Hutter, Jessica S Bolton, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 6, 2003
LY503430, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's diseaseTracey K Murray, Katherine Whalley, Christine S Robinson, et al.
Trials|May 19, 2022
Comparative effectiveness of in-person vs. remote delivery of the Common Elements Treatment Approach for addressing mental and behavioral health problems among adolescents and young adults in Zambia: protocol of a three-arm randomized controlled trialCaleb J Figge, Jeremy C Kane, Stephanie Skavenski, et al.
Plos One|May 4, 2018
Pharmacological characterization of potent and selective NaV1.7 inhibitors engineered from Chilobrachys jingzhao tarantula venom peptide JzTx-VBryan D Moyer, Justin K Murray, Joseph Ligutti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2011
Pretreatment transcriptional profiling for predicting response to neoadjuvant chemoradiotherapy in rectal adenocarcinomaKate H Brettingham-Moore, Cuong P Duong, Danielle M Greenawalt, et al.
Pageof 141